Sex difference in lipid levels in first-diagnosed drug-naïve depression patients: A case-control and 12-weeks follow-up study

References

• Aijanseppa S, Kivinen P, Helkala EL, Kivela SL, Tuomilehto J, Nissinen A. 2002. Serum cholesterol and depressive symptoms in elderly Finnish men. Int J Geriatr Psychiatry. 17(7):629–634.
   PubMed Web of Science ®Google Scholar
• Almeida-Montes LG, Valles-Sanchez V, Moreno-Aguilar J, Chavez-Balderas RA, Garcia-Marin JA, Cortes Sotres JF, Heinze-Martin G. 2000. Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts. J Psychiatry Neurosci. 25(4):371–377.
   PubMed Web of Science ®Google Scholar
• Beydoun MA, Beydoun HA, Dore GA, Fanelli-Kuczmarski MT, Evans MK, Zonderman AB. 2015. Total serum cholesterol, atherogenic indices and their longitudinal association with depressive symptoms among US adults. Transl Psychiatry. 5(3):e518.
   PubMedGoogle Scholar
• Bijl RV, De Graaf R, Ravelli A, Smit F, Vollebergh WA. 2002. Gender and age-specific first incidence of DSM-III-R psychiatric disorders in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 37(8):372–379.
   PubMed Web of Science ®Google Scholar
• Cairney J, Wade TJ. 2002. The influence of age on gender differences in depression: further population-based evidence on the relationship between menopause and the sex difference in depression. Soc Psychiatry Psychiatr Epidemiol. 37(9):401–408.
   PubMed Web of Science ®Google Scholar
• Cyranowski JM, Frank E, Young E, Shear MK. 2000. Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. Arch Gen Psychiatry. 57(1):21–27.
   PubMed Web of Science ®Google Scholar
• Enko DO, Brandmayr W, Halwachs-Baumann G, Schnedl WJ, Meinitzer A, Kriegshauser G. 2018. Prospective plasma lipid profiling in individuals with and without depression. Lipids Health Dis. 17(1):149.
   PubMedGoogle Scholar
• Faravelli C, Alessandra Scarpato M, Castellini G, Lo Sauro C. 2013. Gender differences in depression and anxiety: the role of age. Psychiatry Res. 210(3):1301–1303.
   PubMed Web of Science ®Google Scholar
• Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, Spigset O. 2016. Metabolic abnormalities related to treatment with selective serotonin reuptake inhibitors in patients with schizophrenia or bipolar disorder. J Clin Psychopharmacol. 36(6):615–620.
   PubMed Web of Science ®Google Scholar
• Forlani C, Morri M, Ferrari B, Dalmonte E, Menchetti M, De Ronchi D, Atti AR. 2014. Prevalence and gender differences in late-life depression: a population-based study. Am J Geriatr Psychiatry. 22(4):370–380.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Shields GS, Hegarty JD, Goodwin FK. 2000. Cholesterol levels in mood disorders: high or low? Bipolar Disord. 2(1):60–64.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Tieger M, Kunkel R, Hamer T, Tracy T, Speirs J. 1994. Hypocholesterolemia and affective disorders. Am J Med Sci. 308(4):218–225.
   PubMed Web of Science ®Google Scholar
• Graham I, Cooney MT, Bradley D, Dudina A, Reiner Z. 2012. Dyslipidemias in the prevention of cardiovascular disease: risks and causality. Curr Cardiol Rep. 14(6):709–720.
   PubMed Web of Science ®Google Scholar
• Jerrell JM, Tripathi A, Rizvi AA, McIntyre RS. 2012. The risk of developing type 2 diabetes mellitus associated with psychotropic drug use in children and adolescents: a retrospective cohort analysis. Prim Care Companion CNS Disord. 14(1):PCC.11m01185. DOI:10.4088/PCC.11m01185
   PubMedGoogle Scholar
• Kim HJ, Park HA, Cho YG, Kang JH, Kim KW, Kang JH, Kim NR, Chung WC, Kim CH, Whang DH, et al. 2011. Gender difference in the level of HDL cholesterol in Korean adults. Korean J Fam Med. 32(3):173–181.
   PubMedGoogle Scholar
• Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Ryan CE, Hess AL, Harrison W. 2000. Gender differences in chronic major and double depression. J Affect Disord. 60(1):1–11.
   PubMed Web of Science ®Google Scholar
• Kuwano N, Kato TA, Setoyama D, Sato-Kasai M, Shimokawa N, Hayakawa K, Ohgidani M, Sagata N, Kubo H, Kishimoto J, et al. 2018. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: an exploratory pilot case-control study . J Affect Disord. 231:74–82.
   PubMed Web of Science ®Google Scholar
• Le Melledo JM, Mailo K, Lara N, Abadia MC, Gil L, Van Ameringen M, Baker G, Perez-Parada J. 2009. Paroxetine-induced increase in LDL cholesterol levels. J Psychopharmacol. 23(7):826–830.
   PubMed Web of Science ®Google Scholar
• Ledochowski M, Murr C, Sperner-Unterweger B, Neurauter G, Fuchs D. 2003. Association between increased serum cholesterol and signs of depressive mood. Clin Chem Lab Med. 41(6):821–824.
   PubMed Web of Science ®Google Scholar
• Liebowitz MR, Gelenberg AJ, Munjack D. 2005. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Arch Gen Psychiatry. 62(2):190–198.
   PubMed Web of Science ®Google Scholar
• Lindberg G, Larsson G, Setterlind S, Rastam L. 1994. Serum lipids and mood in working men and women in Sweden. J Epidemiol Community Health. 48(4):360–363.
   PubMed Web of Science ®Google Scholar
• Loas G, Dalleau E, Lecointe H, Yon V. 2016. Relationships between anhedonia, alexithymia, impulsivity, suicidal ideation, recent suicide attempt, C-reactive protein and serum lipid levels among 122 inpatients with mood or anxious disorders. Psychiatry Res. 246:296–302.
   PubMed Web of Science ®Google Scholar
• Mascitelli L, Pezzetta F. 2006. High-density lipoprotein cholesterol and sex difference in coronary heart disease risk. Am J Med. 119(5):e17.
   PubMed Web of Science ®Google Scholar
• Moreira FP, Jansen K, Cardoso TA, Mondin TC, Magalhaes P, Kapczinski F, Souza LDM, da Silva RA, Oses JP, Wiener CD. 2017. Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: population-based study: metabolic syndrome in current depressive episode. J Psychiatr Res. 92:119–123.
   PubMed Web of Science ®Google Scholar
• Morgan RE, Palinkas LA, Barrett-Connor EL, Wingard DL. 1993. Plasma cholesterol and depressive symptoms in older men. Lancet. 341(8837):75–79.
   PubMed Web of Science ®Google Scholar
• Nakao M, Yano E. 2004. Relationship between major depression and high serum cholesterol in Japanese men. Tohoku J Exp Med. 204(4):273–287.
   PubMed Web of Science ®Google Scholar
• Nunes SOV, de Melo LGP, de Castro MRP, Barbosa DS, Vargas HO, Berk M, Maes M. 2015. Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder. J Affect Disord. 172:55–62.
   PubMed Web of Science ®Google Scholar
• Oh J, Kim TS. 2017. Serum lipid levels in depression and suicidality: The Korea National Health and Nutrition Examination Survey (KNHANES) 2014. J Affect Disord. 213:51–58.
   PubMed Web of Science ®Google Scholar
• Olusi SO, Fido AA. 1996. Serum lipid concentrations in patients with major depressive disorder. Biol Psychiatry. 40(11):1128–1131.
   PubMed Web of Science ®Google Scholar
• Ong KL, Morris MJ, McClelland RL, Maniam J, Allison MA, Rye KA. 2016. Lipids, lipoprotein distribution and depressive symptoms: the Multi-Ethnic Study of. Transl Psychiatry. 6(11):e962.
   PubMedGoogle Scholar
• Pan SJ, Tan YL, Yao SW, Xin Y, Yang X, Liu J, Xiong J. 2018. Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression. Acta Pharmacol Sin. 39(9):1463–1472.
   PubMed Web of Science ®Google Scholar
• Persons JE, Fiedorowicz JG. 2016. Depression and serum low-density lipoprotein: a systematic review and meta-analysis. J Affect Disord. 206:55–67.
   PubMed Web of Science ®Google Scholar
• Piazza LA, Markowitz JC, Kocsis JH, Leon AC, Portera L, Miller NL, Adler D. 1997. Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study. Am J Psychiatry. 154(12):1757–1759.
   PubMed Web of Science ®Google Scholar
• Pyykkonen AJ, Raikkonen K, Tuomi T, Eriksson JG, Groop L, Isomaa B. 2012. Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study. Ann Med. 44(3):279–288.
   PubMed Web of Science ®Google Scholar
• Sagud M, Mihaljevic-Peles A, Pivac N, Jakovljevic M, Muck-Seler D. 2009. Lipid levels in female patients with affective disorders. Psychiatry Res. 168(3):218–221.
   PubMed Web of Science ®Google Scholar
• Salk RH, Hyde JS, Abramson LY. 2017. Gender differences in depression in representative national samples: meta-analyses of diagnoses and symptoms. Psychol Bull. 143(8):783–822.
   PubMed Web of Science ®Google Scholar
• Seeman MV. 2009. Secondary effects of antipsychotics: women at greater risk than men. Schizophr Bull. 35(5):937–948.
   PubMed Web of Science ®Google Scholar
• Simons L, Simons J, McCallum J, Friedlander Y. 1993. Serum lipids and depression. Lancet. 341(8851):1028.
   PubMed Web of Science ®Google Scholar
• Sramek JJ, Murphy MF, Cutler NR. 2016. Sex differences in the psychopharmacological treatment of depression. Dialogues Clin Neurosci. 18(4):447–457.
   PubMed Web of Science ®Google Scholar
• Swartz CM. 1990. Albumin decrement in depression and cholesterol decrement in mania. J Affect Disord. 19(3):173–176.
   PubMed Web of Science ®Google Scholar
• Tang M, Jiang P, Li H, Liu Y, Cai H, Dang R, Zhu W, Cao L. 2015. Fish oil supplementation alleviates depressant-like behaviors and modulates lipid profiles in rats exposed to chronic unpredictable mild stress. BMC Complement Altern Med. 15:239.
   PubMed Web of Science ®Google Scholar
• Tedders SH, Fokong KD, McKenzie LE, Wesley C, Yu LL, Zhang J. 2011. Low cholesterol is associated with depression among US household population. J Affect Disorders. 135(1–3):115–121. English.
   PubMed Web of Science ®Google Scholar
• Wu RR, Zhang FY, Gao KM, Ou JJ, Shao P, Jin H, Guo WB, Chan PK, Zhao JP. 2016. Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials. Mol Psychiatry. 21(11):1537–1544.
   PubMed Web of Science ®Google Scholar
• Wu RR, Zhao JP, Guo XF, He YQ, Fang MS, Guo WB, Chen JD, Li LH. 2008. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Am J Psychiatry. 165(3):352–358.
   PubMed Web of Science ®Google Scholar
• Wu X, Huang Z, Wu R, Zhong Z, Wei Q, Wang H, Diao F, Wang J, Zheng L, Zhao J, et al. 2013. The comparison of glycometabolism parameters and lipid profiles between drug-naïve, first-episode schizophrenia patients and healthy controls. Schizophr Res. 150(1):157–162.
   PubMed Web of Science ®Google Scholar
• Young MA, Scheftner WA, Fawcett J, Klerman GL. 1990. Gender differences in the clinical features of unipolar major depressive disorder. J Nerv Ment Dis. 178(3):200–203.
   PubMed Web of Science ®Google Scholar